Unlocking Myasthenia Gravis Efficacy: Navigating Advanced Outcome Measures in Clinical Trials

Clinical TrialsTherapueticsFDA
Written By Corey Hubbard
Unlocking Myasthenia Gravis Efficacy: Navigating Advanced Outcome Measures in Clinical Trials
Glassbury Team

GlassBury Cares Podcast

Episode #29

Corey Hubbard
Previous

WIN378: Windward Bio's Long-Acting TSLP Antibody Poised to Transform Asthma & COPD Care
Next

Nuvectis Pharma's Bold Pivot: NXP800 Exits Ovarian Cancer, NXP900 Leads New Oncology Frontier